Radiation protection serves to protect personnel, the population and the surroundings of nuclear installations against ionising radiation.
ENSI deals with occupational radiological protection, dosimetry, radiation measurement systems, radioactive emissions and environmental monitoring, as well as with the radiological impact of accidents.
News
-
The Spanish regulatory authority and ENSI in talks on radiation protection
From 6 to 8 May 2024, a delegation from the Spanish regulatory authority visited ENSI. Discussions focused on the topic of radiation protection, in particular exchanging of experience relating to the Leibstadt NPP and to the Mühleberg NPP, which is currently being dismantled.
-
Corrigendum to scientific article
Corrigendum to the scientific article “Valid versus invalid radiation cancer risk assessment methods illustrated using Swiss population data”, published on 24 November 2021 in the Journal of Radiological Protection.
-
MADUK: Display of measurement data improved
ENSI has upgraded its MADUK web application. The MADUK monitoring network is used to monitor the radioactivity around nuclear power plants and the Paul Scherrer Institute (PSI).
Background articles
-
Radiation Biology (5/5): Current research in radiation biology
Although many insights have been gained through radiation biology research, many ambiguities still remain. Nevertheless, ENSI, in cooperation with other international organisations, is working towards closing these knowledge gaps.
-
Radiation Biology (4/5): How ionising radiation is measured
Ionising radiation can cause sicknesses. In order to protect the population and personnel working in nuclear installations from these harmful effects, it must be possible to measure radiation doses at any time and as accurately as possible.
-
Radiation Biology (3/5): Low doses and their damage potential
There is no question in radiation biology that the severity of sickness increases at high doses. Nevertheless, it is important when considering everyday radiation protection to be able to estimate the risk of a mutation of the genetic material, and thus the risk of cancer, even in the low dose range.